HNF4A and neoplasm: In this study, to suppress the self-renewal and tumor-initiating capacities of liver CSCs through the inhibition of β-catenin-mediated Wnt signaling, we used CWP232228, a potent small molecule inhibitor that antagonizes the binding of β-catenin to TCF [29].